ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,308.13
0.09%
US Tech 100
18,182.00
0.62%
다우존스 지수
39,806.77
-0.49%
Bitcoin
71,078.31
-0.52%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Poniard Pharmaceuticals, Inc. (MM) (PARD)

  7. Poniard Pharmaceuticals, Inc. (MM) (PARD) 뉴스

PARD

Poniard Pharmaceuticals, Inc. (MM) (PARD)

Poniard Pharmaceuticals, Inc. (MM)
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:PARD
일자시간출처헤드라인심볼기업
2012/01/0322:00MarketwiredPoniard Pharmaceuticals Common Stock to Be Delisted From Nasdaq Stock Market, Intention to List on OTC Bulletin BoardNASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
2011/12/2405:37Edgar (US Regulatory)Current report filing (8-K)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
2011/11/2304:13Edgar (US Regulatory)Current report filing (8-K)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
2011/11/2203:15MarketwiredPoniard Pharmaceuticals Announces Shareholders Approve Merger With ALLOZYNENASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
2011/11/2123:00MarketwiredSteps in the Right Direction - Featured Research on Poniard Pharmaceuticals, Inc. and Gilead Sciences, Inc.NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
2011/11/1903:00Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
2011/11/1822:30MarketwiredPoniard Pharmaceuticals Announces Licensing Agreement for Focal Adhesion Kinase TechnologyNASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
2011/11/1104:54Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
2011/11/1003:16Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
2011/11/0922:30MarketwiredISS Proxy Advisory Services Recommends Poniard Shareholders Vote "FOR" Poniard's Proposed Merger With ALLOZYNE and Reverse St...NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
2011/11/0820:05Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
2011/11/0722:30MarketwiredGlass Lewis Recommends Poniard Shareholders Vote "FOR" Poniard's Proposed Merger With ALLOZYNE and Reverse Stock SplitNASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
2011/11/0419:10Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
2011/11/0305:01Edgar (US Regulatory)Current report filing (8-K)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
2011/10/2905:16Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
2011/10/2905:01MarketwiredPoniard Pharmaceuticals Reports Third Quarter 2011 Financial ResultsNASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
2011/10/2902:59Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
2011/10/2900:19Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
2011/10/2821:30MarketwiredEgan-Jones Recommends Poniard Shareholders Vote "FOR" Poniard's Proposed Merger With ALLOZYNE and Reverse Stock SplitNASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
2011/10/2504:47Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
2011/10/2203:00Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
2011/10/1302:43Edgar (US Regulatory)Current report filing (8-K)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
2011/10/1302:41Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
2011/10/1302:37Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
2011/10/1122:10Dow Jones NewsRegistration Effectiveness Orders Issued By The SECNASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
2011/10/1119:00Edgar (US Regulatory)Notice of Effectiveness (EFFECT)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
2011/10/0806:43MarketwiredPoniard Pharmaceuticals Announces Effectiveness of Form S-4 Registration Statement for the Proposed Merger with ALLOZYNENASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
2011/10/0806:27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
2011/10/0806:26Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
2011/10/0802:22Edgar (US Regulatory)Confidential Treatment Order (CT ORDER)NASDAQ:PARDPoniard Pharmaceuticals, Inc. (MM)
 검색 관련기사 보기:NASDAQ:PARD

최근 히스토리

SPI
SP500
S&P 500
CCOM
SILVER
SILVER
FX
USDEUR
US Dollar vs Euro
CCOM
US500
US 500
NASDAQ
MSFT
Microsoft
AMEX
XLV
Health Care Select Sector
NYSE
CVX
Chevron
NASDAQ
GOOGL
Alphabet
CCOM
US100
US Tech 100
NYSE
AXP
American Express
NYSE
XOM
Exxon Mobil
AMEX
XLF
Financial Select Sector
NYSE
BAC
Bank of America
COIN
SOLUSD
Solana
AMEX
SPY
SPDR S&P 500
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유